Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones. - Wikidata - wikimedia - TriplyDB

Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.

Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.

http://www.wikidata.org/entity/Q41183478

about

Identification of novel genes responsible for overexpression of ampC in Pseudomonas aeruginosa PAO1 Catalytic spectrum of the penicillin-binding protein 4 of Pseudomonas aeruginosa, a nexus for the induction of β-lactam antibiotic resistance Deep sequencing analyses expands the Pseudomonas aeruginosa AmpR regulon to include small RNA-mediated regulation of iron acquisition, heat shock and oxidative stress response.Population structure of clinical Pseudomonas aeruginosa from West and Central African countries.Sequence types 235, 111, and 132 predominate among multidrug-resistant pseudomonas aeruginosa clinical isolates in Croatia.Antibiotic pressure is a major risk factor for rectal colonization by multidrug-resistant Pseudomonas aeruginosa in critically ill patients Draft Genome Sequence of Colistin-Only-Susceptible Pseudomonas aeruginosa Strain ST235, a Hypervirulent High-Risk Clone in Spain.Identification of VIM-2-producing Pseudomonas aeruginosa from Tanzania is associated with sequence types 244 and 640 and the location of blaVIM-2 in a TniC integron.Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection.Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons.The β-lactamase gene regulator AmpR is a tetramer that recognizes and binds the D-Ala-D-Ala motif of its repressor UDP-N-acetylmuramic acid (MurNAc)-pentapeptide Prevalence of resistance to aminoglycosides and fluoroquinolones among Pseudomonas aeruginosa strains in a University Hospital in Northeastern Poland.Using multilocus sequence typing to study bacterial variation: prospects in the genomic era.Dissemination of VIM-2 producing Pseudomonas aeruginosa ST233 at tertiary care hospitals in Egypt.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Within-host microevolution of Pseudomonas aeruginosa in Italian cystic fibrosis patients.Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator.Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.Identification of extensive drug resistant Pseudomonas aeruginosa strains: New clone ST1725 and high-risk clone ST233.Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?Draft Genome Sequence of VIM-2-Producing Multidrug-Resistant Pseudomonas aeruginosa ST175, an Epidemic High-Risk Clone.In Vitro Susceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014).Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing.Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa Fingerprint Analysis and Identification of Strains ST309 as a Potential High Risk Clone in a Pseudomonas aeruginosa Population Isolated from Children with Bacteremia in Mexico City Role of Pseudomonas aeruginosa AmpR on β-lactam and non-β-lactam transient cross-resistance upon pre-exposure to subinhibitory concentrations of antibiotics Evolution and impact of bacterial drug resistance in the context of cystic fibrosis disease and nosocomial settings.New perspectives in the management of Pseudomonas aeruginosa infections.Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review.Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections.Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis.Genomics and Susceptibility Profiles of Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa from Spain.Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art.In Vivo Emergence of Resistance to Novel Cephalosporin-β-Lactamase Inhibitor Combinations through the Duplication of Amino Acid D149 from OXA-2 β-Lactamase (OXA-539) in Sequence Type 235 Pseudomonas aeruginosa.Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria.Acute Inflammatory Response of Patients with Pseudomonas aeruginosa Infections: A Prospective Study.The Threat and Response to Infectious Diseases (Revised).

P2860

Q28492757-A474AFA2-BE76-4788-B6DD-29E804A19E1E Q28493086-BFF9DC58-9991-419C-958F-B5FB810EF2FB Q29346787-66AF36FF-3366-45CE-BFB6-2764FE5553C9 Q34134267-DB3C8807-B326-4235-B766-325245C234E4 Q34298890-EE2F884E-FF8B-4984-985D-9BEFBCCE8E67 Q34298982-FD00736F-6297-4614-B335-6306B21369C2 Q34429763-8406CA5B-BD5F-4AC1-9A60-8DF2A0B24FCA Q34923207-55E8FF1B-2546-43E1-A678-2F78FBE4CB4E Q34948367-C3367B95-91A3-4514-8CCC-8319B88111B2 Q35028183-AA63642F-26CB-4461-B6FB-78F9A2F326BD Q35048806-43796012-61CD-4B4A-93BB-BA4C03052907 Q35069068-E582A6E3-EB12-4E30-A44C-782F72AB397D Q35193523-B7F1A415-0727-48DB-9268-4A89B7FD2587 Q35404121-7CA7910A-47E0-4C70-9835-D4D4429C9046 Q35482558-0EC17653-941B-4751-B44D-358A469F1BA3 Q35813781-49A1BD31-335F-469F-B3E9-6F76A719B63D Q35975439-8321987B-CEFB-4979-8FC3-FCF840D84D52 Q36075893-674A7048-7600-408C-9A76-6F29C25BC42B Q36295260-E2F0C2D8-F3C2-44D4-A173-03022AA34384 Q36757725-D8AB429A-ABDC-4D51-A53E-8539E214E3EA Q36760871-B7D253C3-65D2-406C-9565-F230B8E929C8 Q37120019-D3BCA682-6870-4B5E-81CA-2945214A8CEB Q37409391-E529B9F5-A84B-4872-9DBE-13E3DDB0FDD0 Q37428703-F2A950B7-3F61-4552-AB7A-DED77B900C8C Q37544527-DB634268-E3B3-4988-8353-3368A5804AB4 Q37672430-4F0144DF-D6F3-411D-BD32-BEB82FC4BC19 Q37680591-FC375589-460F-4549-8E88-65E4B2345C85 Q38211644-F9528210-C723-427A-8281-77336351A945 Q38243221-D96CEF10-68DA-45B4-83D6-4BFD9A374CE9 Q38543852-5F659CCF-8529-41AF-980A-9F1DD1D42EE6 Q38599969-C6473C42-4320-4AFB-9838-ED40AE4D1E5D Q38741337-91756679-2D00-40CE-B20E-9FEBE0C6DE97 Q38856197-18019D48-47B2-4856-B922-A470BE4C519E Q39097378-8C37B206-D4F6-4F79-97A7-DCC58F88BE5A Q40056971-59B53DF7-5D98-424B-9B29-6EA0C0823EF3 Q40095692-DFC6F704-F7C9-4F9A-AF2A-F23201EEE03A Q40148490-B5730F40-B48B-47D7-833B-D0CBA9796BC0 Q40346786-CDF89CCC-9B1B-4B45-A53F-0C5D9C9A3460 Q40501527-3436E0BD-BE66-453B-8911-E4641CE5F784 Q40592880-69C84F07-2D72-4FB9-9FBD-47453C48C4CC

P2860

Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.

http://www.wikidata.org/entity/Q41183478

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Genetic markers of widespread ...... s aeruginosa high-risk clones.

@en

type

label

Genetic markers of widespread ...... s aeruginosa high-risk clones.

@en

prefLabel

Genetic markers of widespread ...... s aeruginosa high-risk clones.

@en

P1433

Q41183478-D62DBC3D-6655-46A8-BC20-69495EB76956

P1476

Q41183478-802E8491-EFF8-46BF-BE97-EA4C4018424F

P2093

Q41183478-00252881-A2CA-4BF6-967C-293E3EFCFC26

Q41183478-1F2D81A0-9245-473E-AD47-735BBDB8144E

Q41183478-2D28C077-BFBC-4376-8CA4-DE11484540DE

Q41183478-7C9D4D49-966B-47DA-A5A7-0BC16BCC74E4

Q41183478-8133C031-91D2-4BAB-9DBD-AE7B1F3EEE9B

Q41183478-AC640187-1F5F-4D0E-BC5E-25EEDA46FFF3

Q41183478-C3957869-21C5-4451-8CA2-9CD50C72DE0F

Q41183478-F9718EEA-667D-44AC-A53B-49B9F42270E0

Q41183478-FAC34742-5FF8-4A73-8DD4-48DFA93CB848

P2860

Q41183478-03A07DAF-8C76-49D4-9CB0-CADCA50B7B59

Q41183478-05501264-8EC4-4F85-9246-8A5FE6F51681

Q41183478-05CDB98D-CC6C-4BF8-91CA-6F3C03030B08

Q41183478-171F498B-7E85-4CB8-AE7A-98BB8D615AB6

Q41183478-1FB22B5A-7EAB-4105-AE29-171971158235

Q41183478-2B05F200-0B8A-415F-BBA3-7239A0474632

Q41183478-300BD572-9A1C-4234-AC39-1E21375C63DB

Q41183478-32B12820-EF99-441E-83F6-AB76452E0DC6

Q41183478-40514A4B-9970-41D9-9936-C6A0737138A2

Q41183478-46D78D06-A478-4EC8-9A66-83A62465621C

P304

Q41183478-1D9D3A13-58D9-445D-9A20-AEA42170272F

P31

Q41183478-5FCFBBCB-D937-4F6D-A52C-4872637E300C

P356

Q41183478-1A88DCD3-368A-49E9-8F5A-5ED7BEBF449C

P407

Q41183478-C03EA922-B315-4540-BAA0-6995E97CC4C0

P433

Q41183478-ABB51DBC-E180-4F31-AB5D-D6E4F8BFE664

P478

Q41183478-4F643712-6E94-4976-A34C-4794706E8A45

P50

Q41183478-33183D56-71BF-4612-821F-FE64C32EC1D8

Q41183478-A6DCB156-A742-4AB6-AABA-50914CCB8319

Q41183478-BF0D1424-C3A6-483D-82E9-78BABBA3527B

P577

Q41183478-81CAE93D-E207-49AE-9FB5-2906E8C0CEB8

P698

Q41183478-6FD6527D-9CE9-44BE-8AED-A93995ACE3EA

P921

Q41183478-3380D39E-DE0F-43FF-BC88-1578EE2D4771

P932

Q41183478-E1D567EC-465D-493E-B2E8-07662E02B2E4

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Genetic markers of widespread ...... as aeruginosa high-risk clones

@en

P2093

Alain A Ocampo-Sosa

http://www.w3.org/2001/XMLSchema#string

Antonio Oliver

http://www.w3.org/2001/XMLSchema#string

Bartolomé Moyà

http://www.w3.org/2001/XMLSchema#string

Carmen Peña

http://www.w3.org/2001/XMLSchema#string

Cristina Rodríguez

http://www.w3.org/2001/XMLSchema#string

Fe Tubau

http://www.w3.org/2001/XMLSchema#string

Gabriel Cabot

http://www.w3.org/2001/XMLSchema#string

Juan F Gago

http://www.w3.org/2001/XMLSchema#string

Spanish Network for Research in Infectious Diseases (REIPI)

http://www.w3.org/2001/XMLSchema#string

P2860

mlstdbNet - distributed multi-locus sequence typing (MLST) databases

Crystal structure of the AmpR effector binding domain provides insight into the molecular regulation of inducible ampc beta-lactamase

Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa

The regulatory repertoire of Pseudomonas aeruginosa AmpC ß-lactamase regulator AmpR includes virulence genes

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

Mutational analysis of the catalytic centre of the Citrobacter freundii AmpD N-acetylmuramyl-L-alanine amidase.

A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition.

Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.

Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion

P304

6349-6357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01388-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

M. Angeles Domínguez

Luis Martínez Martínez

P577

2012-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23045355

http://www.w3.org/2001/XMLSchema#string

P921

Pseudomonas aeruginosa

P932

3497190

http://www.w3.org/2001/XMLSchema#string